Cervical Cancer
Black Women in Alabama Dying of Preventable Cancer at Alarming Rate
November 30, 2018
Black Women in Alabama Dying of Preventable Cancer at Alarming Rate
November 29, 2018
Australia is about to eradicate cervical cancer, US is nowhere close. What'll it take?
November 14, 2018
Australia is about to eradicate cervical cancer, US is nowhere close. What'll it take?
November 12, 2018
WHO leads the way towards the elimination of cervical cancer
September 30, 2018
New Clinical Trials Test Immunotherapy for Cervical Cancer
August 8, 2018
Patients being turned away from sexual health clinics, RCN says
May 30, 2018
Nurses have reported having to turn patients away from short-staffed sexual health clinics, leading to fears over a drop in infection testing.
Overstretched resources in the field mean that the public are being left unprotected, according to the Royal College of Nursing (RCN), which launches a report on Monday as sexual health experts warn that services are at “tipping point” due to budget cuts.
New Clinical Trials Test Immunotherapy for Cervical Cancer
March 8, 2018
Two Women Are Building A Pregnancy Test-Like Device To Spot Cervical Cancer
March 8, 2018
One in every 100 women in Europe will develop cervical cancer.
If diagnosed early, this can be treated. Undiagnosed, it spreads into other parts of the body - leading ultimately to death.
Yet life-saving cervical cancer screening is today at an all-time low, with many women skipping so-called ‘PAP smears’ to avoid potential discomfort at the doctors.
Could Making Cancer Screening Simpler Increase Women's Risk?
October 13, 2017
A proposal to simplify cervical cancer screening could end up missing some cancers, researchers and patient advocates say. And that could be especially true for minority women.
Sweetening connection between cancer and sugar
May 30, 2017
Scientists have found that some types of cancers have more of a sweet tooth than others.
What you should know about Cervical Cancer
February 16, 2017
Unlike many gynecologic cancers, there is a vaccination and screening test for cervical cancer, an important distinction in preventing and identifying the disease, according to Ursula Matulonis, MD, medical director of Gynecologic Oncology in Dana-Farber’s Susan F. Smith Center for Women’s Cancers, and Colleen Feltmate, MD, director of minimally invasive surgery in Gynecologic Oncology at Brigham and Women’s Hospital.
Cervical cancer is killing women at a higher rate than previously thought
January 24, 2017
Wider Racial Gap Found in Cervical Cancer Deaths
January 23, 2017
The death rate from cervical cancer in the United States is considerably higher than previously estimated and the disparity in death rates between black women and white women is significantly wider, according to a study published Monday in the journal Cancer.
Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond
June 30, 2015
Despite the declining incidence of cervical cancer as a result of the introduction of screening programs, globally it remains a leading cause of cancer-related death in women. Outcomes for patients who are diagnosed with anything but early-stage disease remain poor.
11 Things You Never Knew to Ask Your Gyno About Cervical Cancer
January 13, 2015
But just because this gynecologic cancer occurs less frequently doesn’t mean it’s less deadly. In fact, cervical cancer was once the No. 1 leading cause of cancer death for women in the US. What’s worse? The disease is almost 100 percent preventable. This fact is especially chilling for Latinas, who have the highest incidence of cervical cancer and the second-highest death rate from the disease.
Half of young women unable to ‘locate vagina'
November 25, 2014
Half of young women are unable to properly label a vagina on a medical diagram, while 65 per cent have admitted they have a problem simply using the words vagina or vulva.
FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer
August 21, 2014
Avastin works by interfering with the blood vessels that fuel the development of cancerous cells. The new indication for cervical cancer is approved for use in combination with chemotherapy drugs paclitaxel and cisplatin or in combination with paclitaxel and topotecan.
Study finds genomic differences in types of cervical cancer
August 19, 2013
A new study has revealed marked differences in the genomic terrain of the two most common types of cervical cancer, suggesting that patients might benefit from therapies geared to each type’s molecular idiosyncrasies.........
.....The research was supported by grants from the American Cancer Society, the Conquer Cancer Foundation of the American Society of Clinical Oncology, the Team Maureen Cervical Cancer Fund, and the Friends of Dana-Farber Cancer Institute.